Medications

Neurosteroid antidepressants on horizon

More than 14 million Americans suffer from clinical depression, yet one in three doesn't experience relief from approved antidepressant drugs. A new treatment approach involving drugs called neurosteroids is on the horizon, ...

Diseases, Conditions, Syndromes

Sickle cell drug showing promise in clinical trial

An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European ...

Diseases, Conditions, Syndromes

Early-stage clinical trial of antimalarial drug begins

Enrollment has begun in a Phase 1 clinical trial to test the safety of a new investigational drug designed to treat malaria, as well as its effect on the human body. The first-in-human study is sponsored by the National Institute ...

page 1 from 12